Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M365Revenue $M26.5Net Margin (%)-132.6Z-Score3.5
Enterprise Value $M325EPS $-0.3Operating Margin %-132.5F-Score4
P/E(ttm))0Cash Flow Per Share $-0.0Pre-tax Margin (%)-132.5Higher ROA y-yN
Price/Book8.810-y EBITDA Growth Rate %-3.8Quick Ratio2.0Cash flow > EarningsY
Price/Sales13.75-y EBITDA Growth Rate %21.7Current Ratio2.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-43.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-62.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M132ROI % (ttm)-30.0Gross Margin Increase y-yY

Gurus Latest Trades with ATRS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ATRSJean-Marie Eveillard 2012-06-30 Sold Out $2.63 - $3.3
($3.04)
$ 2.77-10%Sold Out0
ATRSJean-Marie Eveillard 2010-06-30 Buy $1.48 - $1.95
($1.66)
$ 2.7740%New holding20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ATRS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ATRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JACOB LEONARD SDirector 2015-03-23Sell23,500$2.6810.45 view
Fickenscher James ESenior Vice President & CFO 2014-12-11Buy40,000$2.518.4 view
HOBBS EAMONN PPresident and CEO 2014-09-10Buy9,000$2.234.55 view
ROCHE ROBERT P JRDirector 2014-08-13Buy5,000$1.9651.02 view
JACOB LEONARD SDirector 2014-08-11Buy10,000$1.9849.49 view
SAMSON MARVINDirector 2014-08-11Buy25,000$248 view
GARRITY THOMAS JDirector 2014-08-11Buy5,000$1.9849.49 view
GUETH ANTONDirector 2014-08-11Buy5,000$248 view
JACOB LEONARD SDirector 2014-01-15Sell11,400$5.05-41.39 view
Wotton Paul KPresident and CEO 2014-01-15Sell22,900$5.1-41.96 view

Press Releases about ATRS :

    Quarterly/Annual Reports about ATRS:

    News about ATRS:

    Articles On GuruFocus.com
    Weekly CFO Sells Highlight: ATRS, DENN, TTWO, JAH, ACET Jun 11 2013 

    More From Other Websites
    Initiating Coverage on the Most Compelling Drug Reformulation Story of 2015 Apr 09 2015
    Antares Pharma Announces FDA Approval of TEVTROPIN 10 mg Human Growth Hormone NeedleFree Injector Mar 31 2015
    ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Mar 31 2015
    Antares Pharma Announces FDA Approval of TEV-TROPIN(R) 10 mg (Human Growth Hormone) Needle-Free... Mar 31 2015
    ANTARES PHARMA, INC. Financials Mar 18 2015
    Antares Pharma reports 4Q loss Mar 12 2015
    Antares Pharma reports 4Q loss Mar 12 2015
    Antares Pharma Reports Fourth Quarter and Full Year 2014 Operating and Financial Results Mar 12 2015
    ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 12 2015
    Q4 2014 Antares Pharma Inc Earnings Release - Before Market Open Mar 12 2015
    Antares Pharma Reports Fourth Quarter and Full Year 2014 Operating and Financial Results Mar 12 2015
    Antares Pharma To Host Fourth Quarter 2014 Operating and Financial Results Call Mar 06 2015
    Antares Pharma to Host Fourth Quarter 2014 Operating and Financial Results Conference Call Mar 05 2015
    Antares Pharma Announces Positive Topline Pharmakcokinetic Results From the Quickshot Phase 3 Study... Feb 25 2015
    ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Feb 25 2015
    Antares' testosterone injection meets goal in late-stage study Feb 25 2015
    Antares Pharma Announces Positive Top-Line Pharmacokinetic Results from the QuickShot® Phase 3... Feb 25 2015
    Antares Pharma to Present at the Cowen and Company 35th Annual Healthcare Conference Feb 23 2015
    Antares Pharma to Present at the Cowen and Company 35Th Annual Healthcare Conference Feb 23 2015
    Antares Pharma to Present at the 2015 RBC Capital Markets Global Healthcare Conference Feb 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK